EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant chemotherapy impact on outcomes in immediate breast reconstruction with latissimus dorsi flap and silicone implant

Gabriel Salum D'Alessandro, Alexandre Mendonça Munhoz, Fabiana Midori Takeuchi, Alejandro Povedano, João Carlos Sampaio Góes

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Gabriel Salum D'Alessandro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Plastic Surgery Division, Instituto Brasileiro de Controle do Cancer (IBCC), São Paulo, Brazil. Hauptthemen laut MEDLINE: Superficial Back Muscles, Breast Neoplasms, Mammaplasty. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Neoadjuvant chemotherapy (NCH) has demonstrated efficacy in downsizing tumors and facilitating less extensive surgery. However, immediate breast reconstruction (IBR) after NCH has raised concerns regarding higher complication rates. This study evaluates the impact of NCH on outcomes following IBR with a latissimus dorsi flap and implant (LDI) after mastectomy.

Methods

Cases from a prospective maintained database were reviewed, and patients classified according to whether or not they received NCH. Risk factors and major and minor complications in both groups were then analyzed.

Results

Among the 196 patients who underwent 198 IBR procedures, 38.4% received NCH and 66.1% did not. The overall complication rate was 46.7% in the non‐NCH group and 53.3% in the NCH group ( p = 0.650). The presence of comorbidities increased the likelihood of any complication (odds ratio [OR]: 3.46; 95% confidence interval [CI]: 1.38–8.66; p = 0.008) as well as major complications (OR: 3.35; 95% CI: 1.03–10.95; p = 0.045). Although patients in the NCH group experienced more major complications (10.5% vs. 4.9%; p = 0.134) and early loss of breast reconstruction (3.9% vs. 0.8%; p = 0.128), these findings were not statistically significant.

Conclusion

This study found no statistically significant association between NCH and higher risk of complications or loss of IBR with LDI after mastectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Superficial Back MusclesBreast NeoplasmsMammaplastyHumansFemaleMastectomyNeoadjuvant TherapyTreatment OutcomeProspective StudiesSiliconesRetrospective Studies

Stichwörter der Autor:innen

breast reconstructionlocally advanced breast cancerneoadjuvant chemotherapyoutcome

Substanzen

Silicones

Autor:innen und Institutionen

  • Breast and Plastic Surgery Division, Instituto Brasileiro de Controle do Cancer (IBCC), São Paulo, Brazil.
  • Plastic Surgery Division, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Plastic Surgery Division, Hospital Moriah, São Paulo, Brazil.
  • Plastic Surgery Division, Instituto Brasileiro de Controle do Cancer (IBCC), São Paulo, Brazil.

Zitieren

APA

D'Alessandro, G. S., Munhoz, A. M., Takeuchi, F. M., Povedano, A., & Góes, J. C. S. (2024). Neoadjuvant chemotherapy impact on outcomes in immediate breast reconstruction with latissimus dorsi flap and silicone implant. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27479

Vancouver

D'Alessandro GS, Munhoz AM, Takeuchi FM, Povedano A, Góes JCS. Neoadjuvant chemotherapy impact on outcomes in immediate breast reconstruction with latissimus dorsi flap and silicone implant. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27479

BibTeX
@article{DAlessandro2024,
  author = {D'Alessandro, Gabriel Salum and Munhoz, Alexandre Mendonça and Takeuchi, Fabiana Midori and Povedano, Alejandro and Góes, João Carlos Sampaio},
  title = {Neoadjuvant chemotherapy impact on outcomes in immediate breast reconstruction with latissimus dorsi flap and silicone implant},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27479}
}
Kostenlos starten →